Skip to main content
Top
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Nephrology - Original Paper

Estimated glomerular filtration rate (eGFR), 25(OH) D3, chronic kidney disease (CKD), the MYH9 (myosin heavy chain 9) gene in old and very elderly people

Authors: A. Otero Gonzalez, M. P. Borrajo Prol, M. J. Camba Caride, J. Santos Nores, E. Novoa, C. Perez Melon, P. Macia, M. T. Alves, M. Cid, E. Osorio, E. Coto, J. F. Macias Nuñez

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

It is known that the common physiological denominator of the ageing process is an attenuation of functional performance with respect to the situation of young people and adults. However, since the first cohort-based longitudinal studies, it has not been possible to establish a “linear” relationship between age and glomerular filtration in all cases. This does not mean that there is no physiological ageing process at all; in addition to those already elucidated, its mechanisms include cell senescence, podocyte dysfunction, a vitamin D deficiency, and homozygotic forms of the MYH9 gene. The aim of the present work was to analyse the prevalence of chronic kidney disease (CKD) and, where possible, the correlation between CKD, defined by an eGFR < 60 ml/min/1.73 m2, plasma 25(OH)D3 levels and the MYH9 gene in a population of elderly and very elderly persons. These parameters have not been evaluated previously in populations of elderly and very elderly patients. It is concluded that a moderate decrease in the eGFR occurs with age. This does not imply the presence of CKD in elderly people, since in most individuals the reduced eGFR is not accompanied by anaemia, and no individuals show hypocalcaemia, hyperphosphataemia or a high Alb/Cr ratio. Here we observed a lower Hb level and an elevated Alb/Cr ratio in subjects heterozygotic for the MYH9 gene. This could be interpreted in the sense that the gene could exert some protective effect on renal function, whereas the heterozygotic form (allele A) of the MYH9 gene could be considered a very early marker, a new risk factor for the appearance of CKD, or a sign of renal frailty in elderly people.
Literature
1.
go back to reference Eggers PW (2009) The aging pandemic: demographic changes in the general and end-stage disease population. Semin Nephol 29(6):551–554CrossRef Eggers PW (2009) The aging pandemic: demographic changes in the general and end-stage disease population. Semin Nephol 29(6):551–554CrossRef
2.
go back to reference CDC The state of Aging and Health in American (2007) Report in vol 20079 centers for disease control and prevention CDC The state of Aging and Health in American (2007) Report in vol 20079 centers for disease control and prevention
4.
5.
go back to reference Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:273CrossRef Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:273CrossRef
6.
go back to reference Hemmelgarm BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghall WA, Southern DA, McLaughlin K, Mortis G, Culleton BF (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69(12):2155–2161CrossRef Hemmelgarm BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghall WA, Southern DA, McLaughlin K, Mortis G, Culleton BF (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69(12):2155–2161CrossRef
7.
8.
go back to reference Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Int Med 169(4):342–350CrossRef Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Int Med 169(4):342–350CrossRef
9.
go back to reference Melk A, Ramassar V, Helms LMH, Moore R, Rayner D, Solez K, Halloran PF (2000) Telomere shortening in kidney with age. J Am Soc Nephrol 11:444–453PubMed Melk A, Ramassar V, Helms LMH, Moore R, Rayner D, Solez K, Halloran PF (2000) Telomere shortening in kidney with age. J Am Soc Nephrol 11:444–453PubMed
10.
go back to reference Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ (1997) Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 51(1):230–243PubMedCrossRef Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ (1997) Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 51(1):230–243PubMedCrossRef
12.
go back to reference Bostrom MA, Freedman BI (2010) The spectrum of MYH9-associted nephropathy. Clin J Am Soc Nephrol 5:1107–1113PubMedCrossRef Bostrom MA, Freedman BI (2010) The spectrum of MYH9-associted nephropathy. Clin J Am Soc Nephrol 5:1107–1113PubMedCrossRef
13.
go back to reference Odera K, Goto S, Takahaski R (2007) Age-related change of endocytic receptors megalin and cubilin in the kidney in rats. Biogerentology 8:505–515CrossRef Odera K, Goto S, Takahaski R (2007) Age-related change of endocytic receptors megalin and cubilin in the kidney in rats. Biogerentology 8:505–515CrossRef
14.
go back to reference Marini M, Bruschi M, Pecci A et al (2006) Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Int J Mol Med 17:729–736PubMed Marini M, Bruschi M, Pecci A et al (2006) Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Int J Mol Med 17:729–736PubMed
15.
16.
go back to reference Freedman BI, Hicks PJ, Bostrom MA et al (2009) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75:736–745PubMedCentralPubMedCrossRef Freedman BI, Hicks PJ, Bostrom MA et al (2009) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75:736–745PubMedCentralPubMedCrossRef
17.
go back to reference Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y et al (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40:1185–1192PubMedCrossRef Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y et al (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40:1185–1192PubMedCrossRef
19.
go back to reference Freedman BI, Langefeld CD, Turner J et al (2012) Association of APOL 1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic endstage renal disease. Kidney Int 82:805–811PubMedCentralPubMedCrossRef Freedman BI, Langefeld CD, Turner J et al (2012) Association of APOL 1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic endstage renal disease. Kidney Int 82:805–811PubMedCentralPubMedCrossRef
20.
go back to reference Franceschini N, Voruganti VS, Haack K et al (2010) The association of the MYH9 gene and kidney outcomes in American Indians: the strong heart family study. Hum Genet 127(3):295–301PubMedCentralPubMedCrossRef Franceschini N, Voruganti VS, Haack K et al (2010) The association of the MYH9 gene and kidney outcomes in American Indians: the strong heart family study. Hum Genet 127(3):295–301PubMedCentralPubMedCrossRef
21.
go back to reference Diez-Ojea B, Marin R, Coto E, Tavira B, Fernandez-Vega F, Alvarez R, Fernandez-Fresnedo G, Pobes A, Suarez-Laures A, Garcia-Monteavaro C, Gorostidi M, Sanchez E, Arias M, Ortega F (2014) Association of the MYH9 gene polymorphisms with chronic renal disease secondary to hypertensive nephrosclerosis, in a Caucasian population. Am J Int Med. 2(6):95–101 Diez-Ojea B, Marin R, Coto E, Tavira B, Fernandez-Vega F, Alvarez R, Fernandez-Fresnedo G, Pobes A, Suarez-Laures A, Garcia-Monteavaro C, Gorostidi M, Sanchez E, Arias M, Ortega F (2014) Association of the MYH9 gene polymorphisms with chronic renal disease secondary to hypertensive nephrosclerosis, in a Caucasian population. Am J Int Med. 2(6):95–101
22.
go back to reference Tavira B, Coto E, Gómez J, Tranche S, Miguélez K, Ortega F, Díez B, Sánchez E, Marín R, Arenase J, Alvarez V (2013) Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort. Gene 520(1):73–76PubMedCrossRef Tavira B, Coto E, Gómez J, Tranche S, Miguélez K, Ortega F, Díez B, Sánchez E, Marín R, Arenase J, Alvarez V (2013) Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort. Gene 520(1):73–76PubMedCrossRef
23.
go back to reference Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & rector´s the kidney. Saunders, Philadelphia, pp 535–571 Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & rector´s the kidney. Saunders, Philadelphia, pp 535–571
24.
go back to reference Musso CG, Alvarez Gregori JA, Macías Núñez JF (2008) Renal handling of uric acid, magnesium, phosphorus, calcium and acid base equilibrium in the elderly. In: Macias Nuñez JF, Cameron JS Oreopoulos DG (eds) The aging kidney in health and disease, vol 9, Springer, Secaucus, NJ. pp 155–172 Musso CG, Alvarez Gregori JA, Macías Núñez JF (2008) Renal handling of uric acid, magnesium, phosphorus, calcium and acid base equilibrium in the elderly. In: Macias Nuñez JF, Cameron JS Oreopoulos DG (eds) The aging kidney in health and disease, vol 9, Springer, Secaucus, NJ. pp 155–172
25.
go back to reference Friedman PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurements, mechanism and regulation. Physiol Rev 75:429–471PubMed Friedman PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurements, mechanism and regulation. Physiol Rev 75:429–471PubMed
26.
go back to reference Suki WN, Rose D (1996) Renal transport of calcium, magnesium and phosphate. In: Brenner BM (ed) The Kidney, vol 1., PhiladelphiaPA, Saunders, pp 472–515 Suki WN, Rose D (1996) Renal transport of calcium, magnesium and phosphate. In: Brenner BM (ed) The Kidney, vol 1., PhiladelphiaPA, Saunders, pp 472–515
27.
go back to reference Alvarez-Gregori JA, Robles NR, Mena C, Ardanuy R, Macias-Nuñez JF (2011) The value of a formula including haematocrit, blood urea and gender (HUGE) as a screening test for chronic renal insufficiency. J Nutr Health Aging 15(6):480–484PubMedCrossRef Alvarez-Gregori JA, Robles NR, Mena C, Ardanuy R, Macias-Nuñez JF (2011) The value of a formula including haematocrit, blood urea and gender (HUGE) as a screening test for chronic renal insufficiency. J Nutr Health Aging 15(6):480–484PubMedCrossRef
29.
go back to reference Poggio ED, Rule AD (2009) A critical evaluation of chronic kidney disease. Should one isolated reduced estimated glomerular filtration rate be considered a ‘disease’? Nephrol Dial Transpl 24:698–700CrossRef Poggio ED, Rule AD (2009) A critical evaluation of chronic kidney disease. Should one isolated reduced estimated glomerular filtration rate be considered a ‘disease’? Nephrol Dial Transpl 24:698–700CrossRef
30.
go back to reference Giles PD, Rylance PB, Crothers DC (2008) New results from the modification of diet in renal disease study: the importance of clinical outcomes in test strategies for early chronic kidney disease. QJM 101(2):155–158PubMedCrossRef Giles PD, Rylance PB, Crothers DC (2008) New results from the modification of diet in renal disease study: the importance of clinical outcomes in test strategies for early chronic kidney disease. QJM 101(2):155–158PubMedCrossRef
Metadata
Title
Estimated glomerular filtration rate (eGFR), 25(OH) D3, chronic kidney disease (CKD), the MYH9 (myosin heavy chain 9) gene in old and very elderly people
Authors
A. Otero Gonzalez
M. P. Borrajo Prol
M. J. Camba Caride
J. Santos Nores
E. Novoa
C. Perez Melon
P. Macia
M. T. Alves
M. Cid
E. Osorio
E. Coto
J. F. Macias Nuñez
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1041-x

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.